Mayo Clinic leads biobanking efforts in support of PSC Research

For more than four decades, the Mayo Clinic Division of Gastroenterology and Hepatology has led the field in clinical and scientific discoveries related to Primary Sclerosing Cholangitis (PSC) and has served as the main referral center for PSC in the United States. As a result, Mayo Clinic is home to the largest PSC biobank in the United States, if not the world. Given the rarity of PSC, the biobank containing biospecimens collected from about 1,500 patients represents a critical resource for translational research studies of the disease.

In the following video, Mayo Clinic hepatologist Konstantinos N. Lazaridis, M.D. explains the importance of this biobank, the effort it took to build it, his team’s immediate and future goals and the privilege of studying such a unique collection of biospecimens.